Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE (Q62809446)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
clinical trial

    Statements

    APeX-2 (English)
    0 references
    A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    6 February 2018
    0 references
    October 2020
    0 references
    96
    0 references
    12 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit